NCR Atleos Corp
NATLNYSETechnology · Calculating & Accounting Machines (No Electronic Computers) · MD · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $979.0M | $4.32B | $4.19B | $4.13B | $3.55B |
| Operating income | $93.0M | $449.0M | $271.0M | $269.0M | $248.0M |
| Net income | $14.0M | $91.0M | −$134.0M | $108.0M | $186.0M |
| Total assets | $5.67B | $5.55B | $5.71B | $5.77B | — |
| Total liabilities | $5.27B | $5.29B | $5.47B | $2.51B | — |
| Equity | $403.0M | $260.0M | $246.0M | $3.26B | $2.34B |
| EPS (diluted) | $0.19 | $1.23 | $-1.90 | $1.53 | $2.63 |
| Shares out. | 73.0M | 72.1M | 70.9M | 70.9M | 70.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 9.5%
- Net margin
- 1.4%
- Return on equity
- 3.5%
- Return on assets
- 0.2%
- Return on capital (ROCE)
- 2.5%
- Liabilities / assets
- 92.9%
- Debt / equity
- 13.07×
- Book value / share
- $5.52
- Revenue growth (YoY)
- −77.3%
- Net income growth (YoY)
- −84.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.28distress
- Accruals / assets
- −6.0%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 3 good- Altman Z″ in the distress zone
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Blackrock, Inc.Passive (13G)Oct 17, 2025
- Alliancebernstein L.P.Passive (13G)Oct 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Von Gillern Jeffry H.Director | May 21, 2026 | Grant | 4,351 | $44.82 |
| Reece Joseph EDirector | May 21, 2026 | Grant | 4,351 | $44.82 |
| Niederauer Duncan LDirector | May 21, 2026 | Grant | 4,351 | $44.82 |
| Natoli Frank ADirector | May 21, 2026 | Grant | 4,351 | $44.82 |
| Baker Mary EllenDirector | May 21, 2026 | Grant | 4,351 | $44.82 |
| Almeida OdilonDirector | May 21, 2026 | Grant | 4,351 | $44.82 |
| Hornfeck TraciOfficer — Chief Accounting Officer | Mar 10, 2026 | Grant | 8,977 | $44.56 |
| Burson Andrea RichardsOfficer — Chief Human Resources Officer | Mar 10, 2026 | Grant | 19,404 | $44.56 |
| Nunez Ricardo JOfficer — EVP, General Counsel & Sectry | Mar 10, 2026 | Grant | 34,928 | $44.56 |
| Wamser R Andrew JrOfficer — EVP & Chief Financial Officer | Mar 10, 2026 | Grant | 45,277 | $44.56 |
| Mackinnon StuartOfficer — EVP & Chief Operating Officer | Mar 10, 2026 | Grant | 58,213 | $44.56 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.9M | 1.8 | -13.1% |
| Apr 30, 2026 | 2.1M | 2.5 | +0.8% |
| Apr 15, 2026 | 2.1M | 2.6 | -3.3% |
| Mar 31, 2026 | 2.2M | 1.5 | +47.8% |
| Mar 13, 2026 | 1.5M | 1.0 | -48.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 21, 2026
- Results of operationsMay 6, 2026
- Entered a material agreement · Regulation FD disclosureMar 12, 2026
- Regulation FD disclosureMar 5, 2026
- Entered a material agreement · Regulation FD disclosureFeb 26, 2026
- Results of operationsFeb 26, 2026
- Director / officer changeDec 19, 2025
- Results of operations · Regulation FD disclosureNov 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.